Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Oct;56(10):988-91.

Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection

Kelly A Smart, Krista L Lanctôt, Bosco A Paes
Comment

Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection

Kelly A Smart et al. Can Fam Physician. 2010 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rogovik AL, Carleton B, Solimano A, Goldman R. Palivizumab for the prevention or respiratory syncytial virus infection. Can Fam Physician. 2010;56:769–72. - PMC - PubMed
    1. Samson L. Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Prevention of respiratory syncytial virus infection. Paediatr Child Health. 2009;14(8):521–32. - PMC - PubMed
    1. Committee on Infectious Diseases From the American Academy of Pediatrics: policy statements—modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124(6):1694–701. Epub 2009 Sep 7. - PubMed
    1. Sampalis J, Langley J, Carbonell-Estrany X, Paes B, O’Brien K, Allen U, et al. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Med Decis Making. 2008;28(4):471–80. Epub 2008 Jun 12. - PubMed
    1. Paes B, Steele S, Janes M, Pinelli J. Risk-scoring tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks’ gestational age in Canada. Curr Med Res Opin. 2009;25(7):1585–91. - PubMed

MeSH terms

Substances